Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Toxics
Ilona GórnaEwa Florek

Abstract

The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on th...Continue Reading

References

Nov 15, 1989·Annals of Internal Medicine·E Barrett-Connor, K T Khaw
Jun 1, 1997·Journal of Epidemiology and Community Health·A MolariusS Sans
Jul 20, 1999·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·M VisserD J Deeg
Jul 20, 2001·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·H E Lebovitz
Oct 25, 2001·Yonsei Medical Journal·H S Oh, W S Seo
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Nov 18, 2003·Acta Diabetologica·A De LorenzoA Andreoli
Oct 27, 2004·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M AkbartabartooriC R Hankey
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Carole WilliJacques Cornuz
Apr 11, 2008·The American Journal of Clinical Nutrition·Arnaud ChioleroJacques Cornuz
Feb 25, 2009·The Journal of Biological Chemistry·Haemi LeeJae-Woo Kim
Jan 9, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Bin XieC Anderson Johnson
Sep 14, 2011·Annual Review of Physiology·Paolo Rinaudo, Erica Wang
Oct 25, 2012·Endocrinology·Theodore C FriedmanAmiya P Sinha-Hikim
Nov 23, 2012·Diabetes·Mandeep Bajaj
May 22, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P A HosickD E Stec
Jun 8, 2013·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·P CaponnettoR Polosa
Mar 4, 2014·Therapeutic Advances in Chronic Disease·Daniela SaittaRiccardo Polosa
Apr 16, 2014·Tobacco Control·Tianrong Cheng
May 14, 2014·Circulation·Rachel GranaStanton A Glantz
Jun 1, 2014·Free Radical Biology & Medicine·Brian E Sansbury, Bradford G Hill
Jun 17, 2014·Inhalation Toxicology·Masayuki ItohKazutetsu Aoshiba
Dec 3, 2014·Regulatory Toxicology and Pharmacology : RTP·X Sherwin Yan, Carl D'Ruiz
Jul 5, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·L PonzoniD Braida

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Environmental Research and Public Health·Sung Hoon JeongEun-Cheol Park

❮ Previous
Next ❯

Software Mentioned

CINAHL Plus

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Mehdi AlooshBart Harvey
Pediatric Annals
Stanford T Shulman
The Journal of the American Dental Association
Manas Bajpai
© 2021 Meta ULC. All rights reserved